全球自動化細胞培養市場規模：按產品類型、按應用、按最終用戶、按地區、範圍和預測

自動化細胞培養市場規模及預測

2023年，自動化細胞培養市場的市場規模為249億美元，預計在2024-2030年的預測期內將以8.71%的複合年增長率增長，到2030年將達到455.8億美元。

全球自動化細胞培養市場的市場推動因素

自動化細胞培養市場的市場推動因素可能受到多種因素的影響。

生物製藥需求不斷擴大

自動化細胞培養技術對於優化生產流程變得越來越必要。例如疫苗接種、單株抗體、重組蛋白等。

細胞培養技術發展：

先進細胞培養技術的不斷發展推動了自動化細胞培養解決方案的激增，包括生物反應器、自動化系統和先進細胞培養基的發展。

慢性病盛行率：

隨著糖尿病、癌症和自體免疫疾病等慢性疾病變得越來越普遍，對用於疾病建模、藥物開發和個人化治療的有效細胞培養方法的需求不斷增長。

加大生命科學領域的研發力道：

隨著製藥和生技公司不斷投資研發以創造新的治療方法和療法，對自動化細胞培養技術以提高效率和生產力的需求不斷增加。

關注再生醫學：

對組織工程應用和再生醫學的日益關注產生了對精確和規範的細胞培養程序的需求，推動了自動化細胞培養系統在細胞藥物和組織工程產品生產中的使用。

促進生物技術和生命科學研究的政府支援措施、資助計畫和合作夥伴關係正在推動技術進步和商業化努力，進而推動自動化細胞培養市場的成長。

需要節省成本和時間：

細胞培養程序的自動化降低了成本，減少了人為錯誤的可能性，並加快了生物製藥的上市時間。這些優勢正在推動產業採用自動化細胞培養解決方案。

對個人化醫療的需求不斷增加：

由於基因組學和精準醫學的突破性進展，對可擴展且高度可重複的細胞培養系統的需求日益增長，這些系統可以產生針對患者的特異性治療。這正在推動自動化細胞培養技術市場的發展。

全球自動化細胞培養市場的阻礙因素

有幾個因素可能會成為自動化細胞培養市場的限制和課題。

高初始投資：

由於購買和部署自動化細胞培養系統（包括基礎設施、軟體和設備）所需的初始資本支出，規模較小的生物技術公司和研究機構可能會發現很難進入市場。

整合複雜度：

將自動化細胞培養系統與當前實驗室工作流程和基礎設施整合起來既困難又耗時。這是因為培訓、驗證和客製化需要更多的知識和資源，從而降低了採用率。

相容性問題：

特定細胞類型、培養條件、研究目標和自動化細胞培養技術之間可能存在不相容性。這種不相容性可能會讓人對系統效能、再現性和可靠性產生懷疑，並可能阻礙該技術在各種應用中的廣泛採用。

監理合規課題：

自動化細胞培養系統的製造商和使用者在滿足細胞培養流程、產品安全和資料完整性的嚴格監管要求和品質標準方面面臨課題。這些障礙可能會導致我們產品的商業化和監管審批延遲。

客製化和靈活性限制：

某些自動化細胞培養系統可能無法客製化且不夠靈活，無法滿足特定的研究要求、實驗佈局或不斷變化的科學趨勢。因此，它們在動態研究環境中的可擴展性和有用性可能會受到限制。

資料安全問題：

由於自動化細胞培養系統本質上是數位化的，因此必須考慮資料安全、保密和隱私問題。特別是當涉及敏感研究資料和專有資訊時，組織必須實施強有力的網路安全保障措施並遵守資料保護法。

維護和營運成本：

消耗品、試劑和公用設施只是與自動化細胞培養系統相關的持續成本的一小部分。當這些成本加起來時，就會增加總擁有成本並降低成本效益。

技術過時的風險：

隨著時間的推移，自動化技術和細胞培養方法的快速進步可能會使目前的自動化細胞培養系統過時或過時。保持競爭力並遵守行業標準需要持續投資於升級、更新和培訓。

目錄

第1章簡介

• 市場定義
• 市場細分
• 調查方法

第 2 章執行摘要

• 主要發現
• 市場概況
• 市集亮點

第3章市場概況

• 市場規模和成長潛力
• 市場趨勢
• 市場驅動力
• 市場制約因素
• 市場機會
• 波特五力分析

第4章自動化細胞培養市場：依產品類型

• 自動化細胞培養系統
• 消耗品

第5章自動化細胞培養市場：依應用分類

• 藥物發現和藥物開發
• 生物製藥製造
• 癌症研究
• 幹細胞研究
• 組織工程

第6章 自動化細胞培養市場：依最終使用者分類

• 生物製藥和生物技術公司
• 實驗室和實驗室
• 合約開發組織（CRO）
• 醫院和診斷實驗室

第7章 區域分析

• 北美
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東/非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合酋長國

第8章市場動態

• 市場驅動力
• 市場制約因素
• 市場機會
• COVID-19 的市場影響

第9章競爭格局

• 大公司
• 市場佔有率分析

第10章 公司簡介

• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• Lonza Group Ltd.
• Sartorius AG
• GE Healthcare
• Corning Incorporated
• Asahi Glass Co., Ltd.
• Agilent Technologies
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Fujifilm Holdings Corporation
• Nikon Corporation
• Molecular Devices LLC
• Hamilton Company
• Tecan Group Ltd.
• Brooks Automation, Inc.
• Cell Signaling Technology, Inc.
• Promega Corporation
• Charles River Laboratories International, Inc.

第11章市場前景與機遇

• 新興技術
• 未來市場趨勢
• 投資機會

第12章附錄

• 縮寫表
• 來源和參考文獻

Automated Cell Cultures Market Size And Forecast

Automated Cell Cultures Market size was valued at USD 24.90 Billion in 2023 and is projected to reach USD 45.58 Billion by 2030, growing at a CAGR of 8.71% during the forecast period 2024-2030.

Global Automated Cell Cultures Market Drivers

The market drivers for the Automated Cell Cultures Market can be influenced by various factors. These may include: Demand for Biopharmaceuticals is Growing: In order to optimise production processes, automated cell culture technologies are becoming more and more necessary. Examples of these products include vaccinations, monoclonal antibodies, and recombinant proteins.

Technological Developments in Cell Culture:

The acceptance of automated cell culture solutions is being driven by the continuous development of sophisticated cell culture techniques, including the creation of bioreactors, automated systems, and advanced cell culture media.

Growing Prevalence of Chronic Diseases:

As chronic diseases like diabetes, cancer, and autoimmune disorders become more common, there is an increasing demand for effective cell culture methods for disease modelling, drug development, and personalised treatment.

Growing R&D Efforts in the Life Sciences:

As pharmaceutical and biotechnology businesses continue to spend in research and development to create new cures and treatments, the need for automated cell culture technologies to boost efficiency and productivity is growing.

Focus on Regenerative Medicine:

The increasing attention being paid to tissue engineering applications and regenerative medicine calls for accurate and regulated cell culture procedures, which is propelling the use of automated cell culture systems in the production of cell-based medicines and tissue-engineered goods.

Supportive government initiatives, funding programmes, and partnerships that promote biotechnology and life sciences research are helping to propel technological advancements and commercialization efforts, which in turn is driving the growth of the automated cell cultures market.

Need for Cost and Time Savings:

Automation in cell culture procedures reduces costs, reduces the possibility of human mistake, and quickens the time it takes for biopharmaceutical products to reach market. These benefits encourage the industry to adopt automated cell culture solutions.

Growing Need for Customised Medicine:

As a result of genomics and precision medicine breakthroughs, there is a growing need for scalable and repeatable cell culture systems that can generate patient-specific treatments. This is driving the market for automated cell culture technologies.

Global Automated Cell Cultures Market Restraints

Several factors can act as restraints or challenges for the Automated Cell Cultures Market. These may include:

High Initial Investment:

Smaller biotechnology companies and research institutes may find it difficult to enter the market due to the initial capital expenditure necessary for the acquisition and implementation of automated cell culture systems, which includes infrastructure, software, and equipment.

Complexity of Integration:

It can be difficult and time-consuming to integrate automated cell culture systems with current laboratory workflows and infrastructure. This is because it takes a lot of knowledge and resources for training, validation, and customisation, which lowers adoption rates.

Compatibility Concerns:

There may be incompatibilities between particular cell types, culture conditions, and research goals and automated cell culture technologies. These incompatibilities can raise questions about system performance, reproducibility, and reliability and prevent the technology from being widely adopted in a variety of applications.

Regulatory Compliance Challenges:

Manufacturers and users of automated cell culture systems face difficulties in adhering to strict regulatory requirements and quality standards that govern cell culture processes, product safety, and data integrity. These obstacles can cause delays in the commercialization of their products and regulatory approvals.

Limited Customisation and Flexibility:

Certain automated cell culture systems may not offer enough customisation and flexibility to meet specific research requirements, experimental layouts, or changing scientific trends. As a result, their scalability and usability in dynamic research environments may be limited.

Data Security Issues:

Since automated cell culture systems are digital in nature, there are data security, confidentiality, and privacy issues to be aware of. This is especially true for sensitive research data and proprietary information, which calls for the implementation of strong cybersecurity safeguards and adherence to data protection laws.

Maintenance and Operating Costs:

Consumables, reagents, and utilities are just a few of the ongoing costs that come with automated cell culture systems. These costs can add up to a substantial amount, which raises the total cost of ownership and reduces cost-effectiveness.

Risk of Technological Obsolescence:

Over time, rapid advancements in automation technologies and cell culture methodologies may make current automated cell culture systems obsolete or out of date. To stay competitive and adhere to industry standards, ongoing investments in upgrades, updates, and training are necessary.

Global Automated Cell Cultures Market Segmentation Analysis

The Global Automated Cell Cultures Market is Segmented on the basis of Product Type, Application, End User, and Geography.

Automated Cell Cultures Market, By Product Type

• Automated Cell Culture Systems:
• These encompass fully integrated systems designed to automate various aspects of cell culture, including cell seeding, media exchange, monitoring, and harvesting, offering increased efficiency, reproducibility, and scalability.
• Consumables:
• Consumables such as culture media, reagents, sera, and disposables play a crucial role in automated cell culture workflows, ensuring optimal cell growth, viability, and productivity.

Automated Cell Cultures Market, By Application

• Drug Discovery and Development:
• Automated cell culture systems are extensively used in drug discovery and development processes, including target identification, compound screening, toxicity testing, and lead optimization, facilitating high-throughput screening and accelerated drug development timelines.
• Biopharmaceutical Production:
• Automated cell culture technologies are employed in biopharmaceutical production processes for the large-scale manufacturing of therapeutic proteins, monoclonal antibodies, vaccines, and cell-based therapies, enabling efficient and consistent production yields.
• Cancer Research:
• Automated cell culture systems are utilized in cancer research applications for culturing tumor cells, studying tumor biology, drug response profiling, and screening anticancer agents, contributing to advancements in cancer diagnosis and treatment.
• Stem Cell Research:
• Automated cell culture technologies play a pivotal role in stem cell research applications, including pluripotent stem cell maintenance, differentiation protocols, tissue engineering, and regenerative medicine, facilitating the development of novel cell-based therapies and tissue-engineered products.
• Tissue Engineering:
• Automated cell culture systems are utilized in tissue engineering applications for fabricating functional tissues and organs ex vivo, mimicking physiological conditions and supporting cell proliferation, differentiation, and organization into three-dimensional structures.

Automated Cell Cultures Market, By End User

• Biopharmaceutical and Biotechnology Companies:
• These companies utilize automated cell culture systems for drug discovery, bioprocess development, and biomanufacturing applications, aiming to enhance productivity, reduce costs, and accelerate time-to-market for biopharmaceutical products.
• Research Laboratories and Institutes:
• Academic and research institutions leverage automated cell culture technologies for basic research, translational studies, and preclinical investigations across various disciplines, contributing to scientific advancements and knowledge dissemination.
• Contract Research Organizations (CROs):
• CROs offer automated cell culture services to pharmaceutical, biotechnology, and academic clients for outsourced drug discovery, preclinical testing, and biomanufacturing projects, providing specialized expertise, infrastructure, and resources.
• Hospitals and Diagnostic Laboratories:
• These healthcare facilities employ automated cell culture systems for diagnostic testing, personalized medicine applications, and therapeutic interventions, supporting clinical decision-making and patient care.

Automated Cell Cultures Market, By Geography

• North America:
• Market conditions and demand in the United States, Canada, and Mexico.
• Europe:
• Analysis of the Automated Cell Cultures Market in European countries.
• Asia-Pacific:
• Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa:
• Examining market dynamics in the Middle East and African regions.
• Latin America:
• Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Automated Cell Cultures Market are:
• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• Lonza Group Ltd.
• Sartorius AG
• GE Healthcare
• Corning Incorporated
• Asahi Glass Co., Ltd.
• Agilent Technologies
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Fujifilm Holdings Corporation
• Nikon Corporation
• Molecular Devices LLC
• Hamilton Company
• Tecan Group Ltd.
• Brooks Automation, Inc.
• Cell Signaling Technology, Inc.
• Promega Corporation
• Charles River Laboratories International, Inc.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Automated Cell Cultures Market, By Product Type

• Automated Cell Culture Systems
• Consumables

5. Automated Cell Cultures Market, By Application

• Drug Discovery and Development
• Biopharmaceutical Production
• Cancer Research
• Stem Cell Research
• Tissue Engineering

6. Automated Cell Cultures Market, By End User

• Biopharmaceutical and Biotechnology Companies
• Research Laboratories and Institutes
• Contract Research Organizations (CROs)
• Hospitals and Diagnostic Laboratories

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Thermo Fisher Scientific
• Danaher Corporation
• Merck KGaA
• Lonza Group Ltd.
• Sartorius AG
• GE Healthcare
• Corning Incorporated
• Asahi Glass Co., Ltd.
• Agilent Technologies
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• Fujifilm Holdings Corporation
• Nikon Corporation
• Molecular Devices LLC
• Hamilton Company
• Tecan Group Ltd.
• Brooks Automation, Inc.
• Cell Signaling Technology, Inc.
• Promega Corporation
• Charles River Laboratories International, Inc.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References